Abstract
dc:descriptionImmunogenetic Risk in Parkinson's Disease INTRODUCTION: Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder that arises from the death of dopaminergic neurons in the substantia nigra. The clinical consequences of dopamine deficiency include bradykinesia, tremor, rigidity, and postural instability. PD is recognized as the second most common neurodegenerative disease after Alzheimer’s. The pathophysiology of its sporadic form remains unclear. However, several factors are thought to be involved, including genetic mutations, oxidative stress, dysfunction of dopamine transport mechanisms, as well as inflammatory and immune abnormalities. OBJECTIVE: The aim of this study is to clarify the role of neuroinflammation in the pathogenesis of PD and to explore potential therapeutic approaches by identifying the immunogenetic risk factors associated with the disease. METHODS: Levels of TNF-α (cytokine) and CCL2 (chemokine) were measured in peripheral blood samples collected from PD patients and healthy controls. All biological samples were preserved under deep-freeze conditions. In parallel, data were collected regarding medical history, clinical presentation, disease progression and subtype, treatment regimens, and diagnostic evaluations. Statistical analyses included ANOVA, t-tests, chi-square tests, as well as multivariate logistic regression and survival analysis models. Additionally, a computational gene expression analysis was performed using a selected panel of inflammation-related genes. RESULTS: In the first part of the analysis, TNF-α levels were found to be elevated in the peripheral blood of PD patients compared to controls, with a significant correlation between TNF-α levels and disease severity. Conversely, CCL2 levels did not differ between groups and showed no association with clinical markers of disease progression, such as severity or cognitive decline. In the second part, pathway enrichment analysis was conducted using public gene expression data from PD patients and healthy controls (n = 10 and n = 9, respectively). The enriched pathways in PD samples were primarily related to hematopoiesis and platelet function, cytokine–cytokine receptor interaction, and immune response. Additionally, a downregulation of genes associated with ribosomal function and the spliceosome complex was observed, along with negative regulation of pathways linked to cytoskeletal structure—findings indicative of neuronal vulnerability. Among the selected gene panel, two transcription factors stood out: IRF3 and STAT1. Network analysis of transcription factor–gene regulation identified these as central nodes in multiple inflammatory pathways, suggesting their potential as therapeutic targets for modulating the inflammatory response observed in PD.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Marogianni, Chrysoula
- Μαρογιάννη, Χρυσούλα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59241